intestine." U.S. Food and Drug Administration (2009) FDA Approves PancreaticEnzymeReplacement Product for Marketing in United States: Creon designed to help
Sikkens, E. C. M.; Cahen, D. L.; Kuipers, E. J.; Bruno, M. J. Pancreaticenzymereplacement therapy in chronic pancreatitis. Best Practice & Research. Clinical
S, Yamaguchi K. Prognostic impact of hyaluronan and its regulators in pancreatic ductal adenocarcinoma. PLOS ONE. 2013, 8 (11): e80765. Bibcode:2013PLoSO